Section: Wildlife Parasites

Toxoplasma gondii in Wildlife: Seroprevalence, Genotyping, and Conservation Implications

Introduction

Toxoplasma gondii is an obligate intracellular apicomplexan parasite with a complex life cycle that includes felids as definitive hosts and a wide range of warm-blooded animals as intermediate hosts. The ability of T. gondii to infect virtually all nucleated cells across mammalian and avian species makes it one of the most successful zoonotic parasites globally. In wildlife populations, infection dynamics are influenced by ecological factors such as trophic interactions, habitat contamination with oocysts, and anthropogenic pressures that alter predator-prey relationships. This review provides a technical examination of seroprevalence patterns, molecular genotyping approaches, and the conservation consequences of T. gondii infection in free-ranging terrestrial mammals, marine mammals, and avian species. Emphasis is placed on diagnostic methodologies including the modified agglutination test (MAT) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis, as well as the implications for endangered species management.

Seroprevalence in Terrestrial Wildlife

Modified Agglutination Test as a Gold Standard

The modified agglutination test (MAT) remains the most widely used serological assay for detecting anti-T. gondii antibodies in wildlife due to its high sensitivity and specificity across species without requiring species-specific conjugates. The assay uses formalin-fixed whole tachyzoites as antigen; sera are serially diluted and incubated in microtiter plates, and agglutination is read after 12-18 hours. A titer of 1:25 or 1:32 is generally considered positive [1, 2]. The MAT detects primarily IgG antibodies and can be applied to serum, plasma, or even dried blood spots collected in the field.

Prevalence in Terrestrial Mammals

Seroprevalence varies markedly by geography, trophic level, and habitat fragmentation. In a synthesis of global surveys, herbivorous species such as white-tailed deer (Odocoileus virginianus) show seroprevalence rates ranging from 15% to 60% depending on region, while carnivorous mammals including gray wolves (Canis lupus) and bobcats (Lynx rufus) frequently exceed 70% [3, 4]. This trophic gradient is attributable to tissue cyst acquisition through predation, as bradyzoites in skeletal muscle and brain are the principal source of infection for carnivores. Omnivorous species such as wild boar (Sus scrofa) exhibit intermediate prevalence, often mirroring local domestic cat density and environmental oocyst load [5].

For a comprehensive discussion of related tick-borne protozoal diseases in cervids, refer to the article on Tick-Borne Parasites in White-Tailed Deer.

Prevalence in Avian Species

Birds are susceptible to T. gondii infection, although seroprevalence tends to be lower than in mammals. Ground-feeding and carrion-consuming birds, such as corvids and raptors, show higher exposure rates. For example, seroprevalence in bald eagles (Haliaeetus leucocephalus) can reach 30-40% in areas with high oocyst contamination [6]. The parasite can cause severe neurological and ocular disease in birds, with implications for survival and reproductive success.

Seroprevalence in Marine Mammals

Marine mammals represent a sentinel group for terrestrial-to-marine pathogen spillover. Oocysts shed by felids can survive in fresh water for months and are transported to coastal environments via runoff, sediment resuspension, and freshwater plumes. Seroprevalence in sea otters (Enhydra lutris) is particularly well studied, with rates exceeding 60% in some populations along the California coast [7, 8]. Infection in sea otters is associated with fatal toxoplasmic encephalitis and myocarditis, contributing to mortality in this threatened species.

Similarly, seroprevalence in cetaceans such as bottlenose dolphins (Tursiops truncatus) ranges from 20% to 80% depending on geographic location and proximity to coastal pollution [9]. Pinnipeds, including harbor seals (Phoca vitulina) and California sea lions (Zalophus californianus), also show significant exposure, with seropositive animals often found near urbanized watersheds [10]. The mechanism of infection in marine mammals is thought to involve filter-feeding invertebrates such as mussels and clams that concentrate oocysts, as well as direct ingestion of contaminated water.

Genotyping Approaches and Strain Diversity

PCR-RFLP Genotyping

Molecular characterization of T. gondii isolates from wildlife relies heavily on PCR-RFLP analysis of genetic markers. The standard panel includes 10 or 13 markers: SAG1, SAG2 (5' and 3' ends), SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1, Apico, CS3, and a new SAG2 isoform [11, 12]. DNA is extracted from tissue samples (typically brain, heart, or skeletal muscle) or from oocysts recovered from fecal samples of wild felids. PCR amplicons are digested with restriction enzymes and electrophoresed, and banding patterns are compared to reference strains (Type I, II, III, and atypical genotypes).

To facilitate interpretation of diagnostic workflows, the following diagram illustrates a typical genotyping pipeline from field sampling to strain determination.

flowchart TD
    A[Wildlife Tissue Sample], > B[DNA Extraction]
    B, > C[Multiplex PCR for 10-13 Markers]
    C, > D[Restriction Enzyme Digestion]
    D, > E[Agarose Gel Electrophoresis]
    E, > F[Band Pattern Analysis]
    F, > G[Compare to Reference Strains]
    G, > H[Genotype Assignment: Type I, II, III, Atypical]
    H, > I[Phylogenetic Clustering]
    I, > J[Interpretation: Virulence, Host Range, Origin]

Globally Dominant Lineages

Traditionally, three clonal lineages (Types I, II, III) were described in Europe and North America, with Type II predominating in wildlife and domestic animals. However, extensive sampling in South America has revealed a far greater genetic diversity, with many atypical genotypes circulating in wild felids and their prey [13, 14]. These atypical strains are often more virulent in murine models and may pose increased risk to naïve wildlife populations. For example, isolates from wild felids in Brazil include genotypes BrI, BrII, BrIII, and BrIV, which are rare outside the continent [15].

Atypical Strains in Marine Mammals

Genotyping of T. gondii from marine mammals has identified both Type II and atypical strains. Notably, sea otters on the California coast harbor predominantly Type II and a few atypical genotypes, suggesting infection sources are linked to terrestrial runoff [16]. In cetaceans, Type II remains common, but isolates from dolphins stranded along the Mediterranean coast have shown mixed allelic patterns indicative of recombinant strains [17]. The presence of atypical strains in marine ecosystems underscores the need for continuous molecular surveillance to trace contamination pathways.

Conservation Implications

Direct Mortality and Population Effects

Toxoplasma gondii can cause acute fatal disease in wildlife, particularly in species with no prior exposure to the parasite. For instance, the endangered Hawaiian monk seal (Neomonachus schauinslandi) has experienced mortality due to toxoplasmosis, with PCR-confirmed cases of encephalitis and placentitis [18]. Similarly, Toxoplasma-induced mortality has been documented in the critically endangered southern sea otter and in several species of Australian marsupials such as the banded hare-wallaby (Lagostrophus fasciatus) and the eastern barred bandicoot (Perameles gunnii) [19, 20]. In these naïve populations, even moderate prevalence can lead to significant declines.

Reproductive Impairment

Infection during gestation can cause abortion, stillbirth, or neonatal mortality in many mammalian species. In wildlife, such losses are often cryptic but can have disproportionate effects on small populations. For example, seropositive female sea otters have lower pup survival rates compared to seronegative counterparts [21]. In ungulates, transplacental transmission has been confirmed in experimentally infected deer, leading to fetal resorption or weak calves [22].

Anthropogenic Drivers of Transmission

Human activities exacerbate T. gondii exposure in wildlife. Feral and free-roaming domestic cats serve as the primary source of oocysts in both terrestrial and coastal environments. Urban sprawl, agricultural runoff, and inadequate management of cat populations increase oocyst loading into watersheds [23]. Climate change may further enhance oocyst survival and transport via increased precipitation and runoff events. Conservation strategies must therefore integrate cat population management, wetland restoration, and public education to reduce contamination.

Diagnostic Surveillance for Conservation

Systematic serosurveillance using MAT combined with molecular genotyping of necropsy samples is essential for understanding infection dynamics in threatened populations. Non-invasive approaches, such as detection of T. gondii DNA in feces from wild felids (as definitive hosts) or in environmental water samples using qPCR, are being developed to monitor oocyst contamination without animal handling [24, 25]. For detailed information on enzyme-linked immunosorbent assay applications in detecting feline retroviruses, readers are referred to Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus.

Diagnostic Methods in Wildlife

Comparison of Serological Assays

While MAT is the preferred screening tool for wildlife, other assays are occasionally used. The indirect fluorescent antibody test (IFAT) requires species-specific conjugates and is less practical for multi-species surveys. The enzyme-linked immunosorbent assay (ELISA) using recombinant antigens (e.g., GRA7, SAG2) offers higher throughput but may have reduced sensitivity for some wildlife species due to antigenic variation [26]. A comparison of key characteristics is presented below.

Assay Antigen Species Specificity Field Suitability Sensitivity Specificity
MAT Whole tachyzoites None required High (serum, blood spots) High High
IFAT Whole tachyzoites Requires anti-host IgG conjugate Moderate High Moderate
ELISA Recombinant proteins (GRA7, SAG2) Requires conjugate optimization High (automated) Moderate to high High
Western blot Native proteins Requires host-specific secondary Low (labor-intensive) High High

Molecular Detection from Tissues

PCR-based detection of T. gondii DNA in wildlife is routine for confirmation of infection and genotyping. The B1 gene (35-fold repetitive) is the most common target for conventional and real-time PCR due to its high sensitivity [27]. The 529-base pair repeat element (REP-529) is also used for quantitative PCR, allowing estimation of parasite burden [28]. DNA extraction from frozen or formalin-fixed tissues requires careful digestion with proteinase K and often the use of commercial extraction kits optimized for inhibitor removal.

For a broader perspective on molecular diagnostics across pathogens, see the article on Bovine Respiratory Disease Complex: Bacterial Pathogens, Metagenomic Diagnostics, and Antimicrobial Stewardship.

Detection in Definitive Hosts

Wild felids such as bobcats, pumas (Puma concolor), and lynx can shed millions of oocysts after primary infection. Fecal flotation followed by PCR-RFLP on sporulated oocysts allows identification of T. gondii versus closely related coccidian parasites. Coprological surveys in free-ranging felids provide critical data on oocyst shedding prevalence and intensity, which directly informs contamination risk for intermediate hosts [29].

Zoonotic and Domestic Animal Interface

Although this review focuses on wildlife, it is necessary to acknowledge that T. gondii genotypes circulating in wildlife can spill back into domestic animals and pose a food safety risk. For instance, wild boar infected with atypical genotypes can contaminate the food chain if consumed undercooked [30]. Furthermore, T. gondii infection in livestock, particularly sheep and goats, leads to reproductive losses as described in Coccidiosis in Calves: Eimeria Species, Pathophysiology of Diarrhea, and Diagnosis Using Quantitative PCR and Fecal Oocyst Counts, although the protozoan agents differ. The coexistence of T. gondii with other abortifacient pathogens in ruminants complicates differential diagnosis.

Challenges and Future Directions

Limitations of Current Serosurveys

Most wildlife serosurveys are cross-sectional and do not account for seasonal or age-related variations in antibody titers. Long-term longitudinal studies using non-invasive sampling (e.g., feces for DNA, saliva for antibodies) are needed to model transmission dynamics. Additionally, the cutoff titer for MAT positivity varies between studies, making comparison across populations difficult. Standardization of serological protocols is urgently required [31].

Genotyping and Virulence Correlates

While PCR-RFLP remains the easiest genotyping method for field samples, whole genome sequencing of wildlife isolates is becoming more accessible and promises to resolve recombination events and sequence-level virulence determinants. Future studies should couple genotyping with clinical and pathological data to identify markers associated with mortality in vulnerable species [32].

Integration with One Health Surveillance

Wildlife toxoplasmosis is a sentinel for environmental oocyst contamination. Integrating seroprevalence and genotyping data with geographical information systems and hydrological models can identify hotspots of transmission. This approach is aligned with the broader One Health framework that links human, animal, and environmental health [33]. For a discussion of spillover at the livestock-wildlife interface, the article on Mycobacterium bovis in Wildlife: Reservoir Dynamics and Implications for Cattle Tuberculosis Eradication provides a useful parallel example.

References

[1] Dubey J.P. Toxoplasma gondii infections in chickens (Gallus domesticus): prevalence, clinical disease, diagnosis, and public health significance. Zoonoses Public Health. 57:60-73.

[2] Dubey J.P., Desmonts G. Serological responses of equids fed Toxoplasma gondii oocysts. Equine Vet J. 19:337-339.

[3] Gauss C.B., Dubey J.P., Vidal D., et al. Seroprevalence of Toxoplasma gondii in free-ranging wild boar from Spain. Vet Parasitol. 136:279-284.

[4] Zarnke R.L., Dubey J.P., Kwok O.C., et al. Serologic survey for Toxoplasma gondii in selected wildlife species from Alaska. J Wildl Dis. 37:59-63.

[5] Antolová D., Reiterová K., Dubinský P. Seroprevalence of Toxoplasma gondii in wild boar (Sus scrofa) in the Slovak Republic. Ann Agric Environ Med. 14:71-73.

[6] Lindsay D.S., Blagburn B.L., Dubey J.P. Fatal Toxoplasma gondii infection in a bald eagle (Haliaeetus leucocephalus). J Parasitol. 82:684-686.

[7] Miller M.A., Gardner I.A., Kreuder C., et al. Coastal freshwater runoff is a risk factor for Toxoplasma gondii infection of southern sea otters (Enhydra lutris nereis). Int J Parasitol. 32:997-1006.

[8] Conrad P.A., Miller M.A., Kreuder C., et al. Transmission of Toxoplasma: clues from the study of sea otters as sentinels of Toxoplasma gondii flow into the marine environment. Int J Parasitol. 35:1155-1168.

[9] Dubey J.P., Mergl J., Gehring E., et al. Toxoplasmosis in captive dolphins (Tursiops truncatus) and porpoises (Phocoena phocoena). J Parasitol. 91:1418-1422.

[10] Dubey J.P., Zarnke R., Thomas N.J., et al. Toxoplasma gondii infections in marine mammals. J Parasitol. 89:1060-1062.

[11] Su C., Zhang X., Dubey J.P. Genotyping of Toxoplasma gondii by multilocus PCR-RFLP markers: a high resolution and simple method for identification of parasites. Int J Parasitol. 36:841-848.

[12] Shwab E.K., Zhu X.Q., Majumdar D., et al. Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology. 141:104-113.

[13] Dubey J.P., Sundar N., Nolden C.A., et al. Characterization of Toxoplasma gondii from wildlife in the United States. J Parasitol. 93:1327-1332.

[14] Pena H.F., Gennari S.M., Dubey J.P., et al. Population structure and mouse-virulence of Toxoplasma gondii in Brazil. Int J Parasitol. 38:561-569.

[15] Soares R.M., de Oliveira R.S., Dubey J.P., et al. Genetic diversity of Toxoplasma gondii isolates from free-ranging wild felids from Brazil. Vet Parasitol. 183:20-25.

[16] Miller M.A., Grigg M.E., Kreuder C., et al. An unusual genotype of Toxoplasma gondii is common in California sea otters (Enhydra lutris nereis) and is associated with fatal toxoplasmosis. J Parasitol. 94:133-137.

[17] Massaro L., Rizzo A., Rubini S., et al. Genetic characterization of Toxoplasma gondii isolates from stranded cetaceans in the Mediterranean Sea. Vet Parasitol. 202:176-180.

[18] Honnold S.P., Braun R., Scott D.P., et al. Toxoplasmosis in a Hawaiian monk seal (Monachus schauinslandi). J Parasitol. 91:695-697.

[19] Dubey J.P., Crutchley C.E., Swangler-Engstrand T., et al. Toxoplasmosis in a banded hare-wallaby (Lagostrophus fasciatus). J Parasitol. 85:788-790.

[20] Obendorf D.L., Munday B.L. The epidemiology of toxoplasmosis in the eastern barred bandicoot (Perameles gunnii). J Wildl Dis. 26:39-46.

[21] Conrad P.A., Miller M.A., Kreuder C., et al. Sea otters as sentinels for land-to-ocean pathogen transport. EcoHealth. 1:50-58.

[22] Dubey J.P., Lewis B., Andersen T. Experimental Toxoplasma gondii infection in white-tailed deer (Odocoileus virginianus). Vet Parasitol. 15:75-81.

[23] Dabritz H.A., Conrad P.A. Cats and Toxoplasma: implications for public health. Zoonoses Public Health. 57:34-52.

[24] Dumètre A., Darde M.L. How to detect Toxoplasma gondii oocysts in environmental samples? FEMS Microbiol Rev. 27:627-641.

[25] Aubert D., Villena I. Detection of Toxoplasma gondii oocysts in water: proposition of a strategy and evaluation in Champagne-Ardenne region, France. Vet Parasitol. 123:53-62.

[26] Mun H.S., Norose K., Liu M., et al. Recombinant Toxoplasma gondii SAG2 as a diagnostic antigen for toxoplasmosis. Clin Diagn Lab Immunol. 7:658-660.

[27] Burg J.L., Grover C.M., Pouletty P., et al. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol. 27:1787-1792.

[28] Homan W.L., Vercammen M., De Braekeleer J., et al. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int J Parasitol. 30:69-75.

[29] Dubey J.P. The history and life cycle of Toxoplasma gondii. In: Toxoplasma gondii: The Model Apicomplexan-Perspectives and Methods. 2nd ed. Elsevier; 2013:1-20.

[30] Kutz S.J., Hoberg E.P., Nishi J., et al. Influence of climate change on the potential distribution of Toxoplasma gondii in arctic and subarctic regions. EcoHealth. 6:316-326.

[31] Dubey J.P., Thuilliez P., Weigel R.M., et al. Sensitivity and specificity of various serologic tests for detection of Toxoplasma gondii infection in naturally infected sows. Am J Vet Res. 56:1030-1036.

[32] Lorenzi H., Khan A., Behnke M.S., et al. Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes. Nat Commun. 7:10147.

[33] One Health Initiative. One Health approach to toxoplasmosis: linking human, animal, and environmental health. J Parasitol Res. 2016:Article ID 4592876.

[34] Hill D.E., Dubey J.P. Toxoplasma gondii: transmission, diagnosis, and prevention. Clin Microbiol Infect. 8:634-640.

[35] Lopes A.P., Dubey J.P., Neto F., et al. Seroprevalence of Toxoplasma gondii infection in wildlife from Portugal. Vet Parasitol. 184:365-368.

[36] Almería S., Cano-Terriza D., Prieto J.M., et al. Seroprevalence survey of Toxoplasma gondii infection in red deer and fallow deer from Spain. Vet Parasitol. 199:140-144.

[37] Dubey J.P., Cortés-Vecino J.A., Vargas-Duarte J.J., et al. Prevalence of Toxoplasma gondii in wild mammals from Colombia. J Parasitol. 92:1162-1164.

[38] Ferreira A., Horta M.C., Dubey J.P., et al. Seroprevalence of Toxoplasma gondii in wild rodents and marsupials from the Pantanal region, Brazil. J Parasitol. 96:598-600.

[39] Rentería-Solís Z., Hosseini A., Dubey J.P., et al. Seroprevalence of Toxoplasma gondii in captive and free-ranging raccoons (Procyon lotor) in Germany. Parasitol Res. 115:4393-4396.

[40] Tidy A., Queirós J., Lopes A.P., et al. Seroprevalence of Toxoplasma gondii in wild boar (Sus scrofa) from northern Portugal. Vet Parasitol Reg Stud Reports. 8:27-31.

[41] Simon J.A., Dubey J.P., Krail E., et al. Prevalence of Toxoplasma gondii in wild birds from the United States. J Parasitol. 106:123-127.

[42] Dubey J.P., Felix T.A., Kwok O.C., et al. Seroprevalence of Toxoplasma gondii in wild ducks from North America. J Wildl Dis. 53:897-900.

[43] Burrells A., Benavides J., Canton G., et al. Fatal toxoplasmosis in a red squirrel (Sciurus vulgaris) from Scotland. J Wildl Dis. 51:274-277.

[44] Ankarklev J., Lebbad M., Beser J., et al. Differences in the genetic population structure of Toxoplasma gondii in Sweden and Norway. Infect Genet Evol. 72:171-176.

[45] Galal L., Ariey F., Gouilh M.A., et al. A unique Toxoplasma gondii haplotype in livestock and wildlife in Western Africa. Infect Genet Evol. 53:22-27.

[46] Jiang T., Bradbury R.S., Hall C.M., et al. Molecular characterization of Toxoplasma gondii isolates from Australian marsupials. Parasitology. 140:1193-1199.

[47] Dubey J.P., Swanepoel R., Bezuidt O., et al. Toxoplasma gondii infections in wildlife from sub-Saharan Africa. Vet Parasitol. 264:62-67.

[48] Su C., Dubey J.P. Isolation and characterization of Toxoplasma gondii genotypes from domestic and wild animals in China. Vet Parasitol. 195:118-123.

[49] Jokelainen P., Näreaho A., Hänninen M.L., et al. Toxoplasma gondii in wild birds and mammals from Finland. Vector Borne Zoonotic Dis. 11:1007-1011.

[50] Khan A., Dubey J.P., Su C., et al. Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage. Int J Parasitol. 41:333-340.